In this study, a large cohort of MDS patients was recruited to correlate the mRNA expression of five angiogenic factors including VEGF-A, VEGF-C, Ang-1, Ang-2 and the receptor Tie2 in the BM with the clinical outcome. This evidence concerns the gene TEK and myelodysplastic syndrome.